Navigation Links
Video: CVS/pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide
Date:6/8/2009

National Campaign runs from June 7 - 27

WOONSOCKET, R.I., June 8 /PRNewswire/ -- CVS/pharmacy has kicked-off its annual in-store fundraising campaign to support the fight against amyotrophic lateral sclerosis (ALS). Since 2002, CVS/pharmacy has partnered with the ALS Therapy Alliance (ATA) to help advance ALS research. To date, CVS/pharmacy has raised more than $15 million in its stores -- a single $1 donation at a time -- to support the funding of new clinical trials with the aim of discovering a treatment or cure for this devastating disease. This year's campaign runs through June 27.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/CVS/38728/

To bring the campaign to a personal level and to communicate the randomness of the disease, the story of a young mother with ALS will be shared throughout the campaign. Dana Miller, a 45-year-old resident of Wayland, Mass. and a mother of four who is married to a childhood friend, was diagnosed with ALS just six months ago. She is serving as honorary co-chair of this year's campaign along with Jon Roberts, Executive Vice President of CVS Caremark.

For Miller, the disease seemed to come out of nowhere. "One minute, I was exercising as usual and the next minute, the weights I was holding were falling out of my hands. I really knew something was wrong when I was on the treadmill and couldn't get my foot to move forward."

"Unfortunately, my symptoms have progressed rapidly and I now have difficulty walking, moving my hands and arms, and speaking," Miller added. "I'm also unable to drive. The hardest part of all of this though, is the impact that ALS has had on my family."

By serving as co-chair of CVS/pharmacy's in-store fundraising campaign, Miller aims to turn a negative into a positive -- championing funding for ALS research. "Funding for ALS research is critical to finding a cure for this debilitating disease and I want to play a role in raising funds so that others diagnosed with this disease can benefit from medical advances," she said.

ALS is a disorder in which there is progressive degeneration of motor nerves in the brain and spinal cord leading to paralysis and death, typically within three to five years. There is no known cause or cure for ALS, which affects 25,000 Americans, with 5,000 new cases diagnosed each year.

Added campaign co-chair Roberts, "What Dana is doing by sharing her story publicly is admirable and brave. By putting a face on this debilitating disease, Dana hopes to motivate CVS/pharmacy customers to play a role in making a difference in the quest to cure ALS. Our customers have come through for us consistently over the years, and we're confident that they'll do so again this year -- especially knowing that 100 percent of funds raised through the campaign will go directly to the ALS Therapy Alliance to fund their groundbreaking research."

Dr. Robert H. Brown, Jr., who is Executive Director of ALS Therapy Alliance, said, "More has happened with research in the last six months than in the previous few years, and continued research is critical to finding a cure for ALS. We're on the cusp of a major advancement in understanding the disease and finding new treatments. Funding provided through the CVS/pharmacy campaign is pivotal to making further progress possible. We're extremely grateful for the support that CVS/pharmacy and its customers have provided over the years and look forward to another successful year."

About ALS Therapy Alliance (ATA)

ATA was founded in 2000 to provide a vehicle for a diverse group of scientists and clinicians to coordinate research related to ALS. The scientists involved in the ATA are affiliated with some of the best universities and medical centers, including, among others, Massachusetts General Hospital, Harvard Medical School, Massachusetts Institute of Technology, Harvard College, Brigham and Women's Hospital, Beth Israel Deaconess Hospital, Boston University and the University of Massachusetts. ATA's board is comprised of outstanding clinicians, scientists and business associates including two Nobel Prize Laureates, H. Robert Horwitz, Ph.D. and Craig C. Mello, Ph.D., who are committed to the organization's mission. CVS Caremark is the largest corporate donor to the ALS Therapy Alliance.

About CVS/pharmacy

CVS/pharmacy, the retail division of CVS Caremark Corporation (NYSE: CVS), is America's largest retail pharmacy. The Company operates more than 6,900 CVS/pharmacy and Longs Drugs stores. CVS/pharmacy is committed to providing expert care and innovative solutions in pharmacy and health care that are effective and easy for our customers, both in its stores and online at CVS.com. General information about CVS/pharmacy and CVS Caremark is available at www.CVScaremark.com.

Press Contact:

    Carolyn Castel
    CVS/pharmacy
    (401) 770-5717
    ccastel@CVS.com
    Dawn Ratte
    401-453-4748 or 401-580-9597 (Cell)
    dratte@addventures.com 


'/>"/>
SOURCE CVS/pharmacy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Video: Bon Secours Finds Young Families are In Line With National Economic Trend
2. Video: Plan for Long Term Care Before the Crisis Hits
3. Video: truth(R) Asks: Do You Have What it Takes?
4. Video: NSF Enlists Renowned Womens Health Expert to School America on Sleeping Smart
5. Video: Schering-Plough Introduces TINACTIN(R) CHILL, a Line of Antifungal Products Geared Specifically to Young Males
6. Video: GoGirl!, Dont Take Life Sitting Down
7. Video: CVS/pharmacy and National Council on Aging Help Seniors Get the Cost-Saving Benefits they Need
8. Video: AccuVein Launches First Portable, Non-Contact Vein Illumination Device
9. Video: Academy Award(R) Winner Olympia Dukakis and Husband, Actor Louis Zorich, Encourage Older Adults to Ask.Screen.Know.
10. Video: Novartis Receives Approval From FDA to Market Prevacid(R) 24HR as First and Only OTC Proton Pump Inhibitor in Original Prescription Formulation
11. Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although ... the majority of skin cancer deaths. More than 10,000 people are expected to die of ... is 62, it is the one of the most commonly diagnosed cancers in young women. ...
(Date:4/29/2016)... ... , ... For those who skip meals occasionally (which is pretty much everyone), ... many new lifestyle diet tips offered by nutritionists Pam Bonney and Priya Lawrence of ... show. Bonny and Lawrence noted that because proper nutrition, including water, provides energy during ...
(Date:4/29/2016)... ... April 29, 2016 , ... CURE Media ... on patients with cancer, today announced that Lynne Malestic, RN, of Eisenhower Lucy ... CURE® Extraordinary Healer® for Oncology Nursing , which honors nurses who have dedicated ...
(Date:4/29/2016)... ... April 29, 2016 , ... International Dehydrated Foods, Inc. (IDF™) will attend and ... at the Doubletree by Hilton Hotel in Oak Brook, Illinois. The two-day event is ... for protein ingredients. , At the seminar, IDF™ will offer samples of its Savory ...
(Date:4/29/2016)... ... April 29, 2016 , ... Intellitec Solutions ... May 16th to 18th at the Broward County Convention Center. The event is ... collaborate on best practices in public facility management. Intellitec Solutions will highlight their ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... YORK , April 28, 2016  The blood ... 275 million dollars, according to Kalorama Information and The ... typing, immunoassays and nucleic acid testing.  The healthcare research ... made progress in developing blood collection stations and in ... made in Kalorama Information,s report, Blood Testing ...
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
(Date:4/28/2016)... JERUSALEM , April 28, 2016 ... ), a clinical-stage pharmaceutical company focused on the development of ... participate in the upcoming PIONEERS 2016 conference, presented by ... 5, 2016 in New York . ... overview at the conference. Presentation Details:   ...
Breaking Medicine Technology: